Scarica l'app Stockscreener
15.90
3.23%
-0.53
Dopo l'orario di chiusura:
15.90
Enanta Pharmaceuticals Inc Borsa (ENTA) Ultime notizie
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
What makes Enanta Pharmaceuticals Inc. stock attractive to growth fundsTrend Following Strategies & Affordable Trading Portfolio - Bollywood Helpline
Enanta Pharmaceuticals (ENTA) Surges 5.9%: Is This an Indication of Further Gains? - Yahoo Finance
What hedge fund activity signals for Enanta Pharmaceuticals Inc. stock2025 Market Outlook & Daily Growth Stock Investment Tips - Улправда
How Enanta Pharmaceuticals Inc. stock performs in interest rate cycles2025 Geopolitical Influence & Technical Pattern Recognition Alerts - Улправда
Does Enanta Pharmaceuticals Inc. stock trade at a discount to peersMarket Movement Recap & Smart Allocation Stock Tips - Улправда
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Stock Catapults 27% Though Its Price And Business Still Lag The Industry - simplywall.st
Rate Hike: Will Enanta Pharmaceuticals Inc. stock see insider buyingTrade Performance Summary & Daily Profit Focused Stock Screening - Улправда
Will Enanta Pharmaceuticals Inc. (9EP) stock see insider accumulationTrade Risk Report & Long-Term Safe Investment Ideas - Улправда
What margin trends mean for Enanta Pharmaceuticals Inc. stockJuly 2025 Retail & Free Verified High Yield Trade Plans - Улправда
Why Enanta Pharmaceuticals Inc. stock is considered a top pickMarket Activity Summary & Precise Trade Entry Recommendations - Улправда
Will Enanta Pharmaceuticals Inc. stock benefit from upcoming earnings reportsRate Hike & Accurate Technical Buy Alerts - Bölüm Sonu Canavarı
Aug Breakouts: Will Enanta Pharmaceuticals Inc. (9EP) stock outperform Dow Jones2025 Market Sentiment & Weekly High Momentum Picks - Улправда
Is Enanta Pharmaceuticals Inc. stock a buy in volatile marketsJuly 2025 Retail & Low Drawdown Momentum Ideas - DonanımHaber
Will Enanta Pharmaceuticals Inc. stock benefit from automation2025 Earnings Impact & AI Based Buy/Sell Signal Reports - DonanımHaber
Will Enanta Pharmaceuticals Inc. stock see insider buyingMarket Trend Report & Fast Exit and Entry Strategy Plans - Улправда
Why Enanta Pharmaceuticals Inc. stock appeals to analystsStop Loss & Expert Approved Trade Ideas - DonanımHaber
Is Enanta Pharmaceuticals Inc. stock trading at a premium valuation2025 Price Targets & Fast Entry Momentum Trade Alerts - Улправда
(ENTA) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Enanta Pharmaceuticals (NASDAQ:ENTA) Share Price Crosses Above 200-Day Moving AverageWhat's Next? - MarketBeat
Have Insiders Sold Enanta Pharmaceuticals Shares Recently? - simplywall.st
Enanta Pharmaceuticals falls on public offering of common stock - MSN
Enanta Pharmaceuticals (NASDAQ:ENTA) Insider Scott Rottinghaus Sells 798 Shares - MarketBeat
Enanta Pharmaceuticals (NASDAQ:ENTA) CEO Jay Luly Sells 4,743 Shares of Stock - MarketBeat
Enanta Pharma chief medical officer sells $11k in stock By Investing.com - Investing.com Canada
Tara Lynn Kieffer Sells 2,106 Shares of Enanta Pharmaceuticals (NASDAQ:ENTA) Stock - MarketBeat
Enanta Pharma CBO Luu sells $19,836 in stock By Investing.com - Investing.com Canada
Enanta Pharma CBO Luu sells $19,836 in stock - Investing.com India
Enanta Pharma CSO Or Yat Sun sells $34k in stock - Investing.com India
Enanta Pharma CSO Or Yat Sun sells $34k in stock By Investing.com - Investing.com South Africa
Enanta Pharma chief product officer sells $30k in stock By Investing.com - Investing.com UK
Will Enanta Pharmaceuticals Inc. (9EP) stock extend growth storyJuly 2025 Intraday Action & Daily Profit Focused Screening - Newser
Can Enanta Pharmaceuticals Inc. (9EP) stock survive global slowdownJuly 2025 PostEarnings & Consistent Profit Focused Trading Strategies - Newser
Is Enanta Pharmaceuticals Inc. (9EP) stock nearing a technical breakout - Newser
Is Enanta Pharmaceuticals Inc. stock a top momentum playQuarterly Market Summary & Risk Controlled Daily Trade Plans - Newser
VP Or Surrenders 753 Of Enanta Pharmaceuticals Inc [ENTA] - TradingView
ENTA: RSV and immunology pipelines advance with key candidates and pivotal trials planned for 2026 - TradingView
Is Enanta Pharmaceuticals Inc. (9EP) stock a defensive play amid uncertainty - Newser
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Certain Options of Enanta Pharmaceuticals, Inc. are subject to a Lock-Up Agreement Ending on 30-NOV-2025. - marketscreener.com
Certain Common Stock of Enanta Pharmaceuticals, Inc. are subject to a Lock-Up Agreement Ending on 30-NOV-2025. - marketscreener.com
Portfolio Recap: What makes Enanta Pharmaceuticals Inc. stock attractive to growth funds2025 Winners & Losers & Risk Adjusted Swing Trade Ideas - moha.gov.vn
Enanta Pharmaceuticals Inc Stock Analysis and ForecastMarket Capitalization Trends & Free Unmatched Market Performance - earlytimes.in
Enanta Pharmaceuticals, Inc. (ENTA) Analyst insights, Price targets and Recommendations - Yahoo Finance UK
Enanta Pharmaceuticals insider awarded RSUs and 12,925 stock options - Stock Titan
[Form 4] ENANTA PHARMACEUTICALS INC Insider Trading Activity - Stock Titan
0.23%
0.08%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):